Jinyu Bio Revenue vs. Shares Outstanding
| 600201 Stock | 7.84 0.44 5.95% |
Total Revenue | First Reported 2002-03-31 | Previous Quarter 263.8 M | Current Value 359.1 M | Quarterly Volatility 149.5 M |
For Jinyu Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Jinyu Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Jinyu Bio Technology Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Jinyu Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Jinyu Bio Technology Co over time as well as its relative position and ranking within its peers.
Jinyu |
Jinyu Bio Technology Shares Outstanding vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Jinyu Bio's current stock value. Our valuation model uses many indicators to compare Jinyu Bio value to that of its competitors to determine the firm's financial worth. Jinyu Bio Technology Co is the top company in revenue category among its peers. It also is number one stock in shares outstanding category among its peers creating about 0.70 of Shares Outstanding per Revenue. The ratio of Revenue to Shares Outstanding for Jinyu Bio Technology Co is roughly 1.43 . At present, Jinyu Bio's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Jinyu Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Jinyu Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Jinyu Revenue vs. Competition
Jinyu Bio Technology Co is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 8.73 Trillion. Jinyu Bio adds roughly 1.6 Billion in revenue claiming only tiny portion of equities under Health Care industry.
Jinyu Shares Outstanding vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Jinyu Bio |
| = | 1.6 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Jinyu Bio |
| = | 1.12 B |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Jinyu Shares Outstanding Comparison
Jinyu Bio is currently under evaluation in shares outstanding category among its peers.
Jinyu Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Jinyu Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Jinyu Bio will eventually generate negative long term returns. The profitability progress is the general direction of Jinyu Bio's change in net profit over the period of time. It can combine multiple indicators of Jinyu Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 324.8 M | 316.5 M | |
| Income Before Tax | 315.8 M | 312.9 M | |
| Net Income Applicable To Common Shares | 242.3 M | 261.6 M | |
| Net Income | 283.6 M | 263.7 M | |
| Income Tax Expense | 52.3 M | 49.2 M | |
| Net Income From Continuing Ops | 277.1 M | 378.1 M | |
| Total Other Income Expense Net | 102.7 M | 57.1 M | |
| Net Interest Income | 56.2 M | 36.6 M | |
| Interest Income | 56.5 M | 39.6 M | |
| Change To Netincome | 59.1 M | 62.1 M |
Jinyu Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Jinyu Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Jinyu Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Jinyu Bio's important profitability drivers and their relationship over time.
Use Jinyu Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jinyu Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jinyu Bio will appreciate offsetting losses from the drop in the long position's value.Jinyu Bio Pair Trading
Jinyu Bio Technology Co Pair Trading Analysis
The ability to find closely correlated positions to Jinyu Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jinyu Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jinyu Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jinyu Bio Technology Co to buy it.
The correlation of Jinyu Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jinyu Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jinyu Bio Technology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jinyu Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Jinyu Bio position
In addition to having Jinyu Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banking Thematic Idea Now
Banking
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Jinyu Stock
To fully project Jinyu Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Jinyu Bio Technology at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Jinyu Bio's income statement, its balance sheet, and the statement of cash flows.